Wang WY - Search Results

1

Dicer deficiency impairs proliferation but potentiates anti-tumoral effect of macrophages in glioblastoma.

Liu YQ, Luo M, Shi Y, Guo Y, Zhang H, Yang KD, Li TR, Yang LQ, Liu TT, Huang B, Liu Q, He ZC, Zhang XN, Wang WY, Wang S, Zeng H, Niu Q, Zhang X, Cui YH, Zhang ZR, Bian XW, Ping YF. Liu YQ, et al. Among authors: wang wy, wang s. Oncogene. 2022 Jul;41(30):3791-3803. doi: 10.1038/s41388-022-02393-9. Epub 2022 Jun 28. Oncogene. 2022. PMID: 35764885

2

Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance.

Shi Y, Guryanova OA, Zhou W, Liu C, Huang Z, Fang X, Wang X, Chen C, Wu Q, He Z, Wang W, Zhang W, Jiang T, Liu Q, Chen Y, Wang W, Wu J, Kim L, Gimple RC, Feng H, Kung HF, Yu JS, Rich JN, Ping YF, Bian XW, Bao S. Shi Y, et al. Sci Transl Med. 2018 May 30;10(443):eaah6816. doi: 10.1126/scitranslmed.aah6816. Sci Transl Med. 2018. PMID: 29848664 Free PMC article.

3

Stromal PD-1⁺ tumor-associated macrophages predict poor prognosis in lung adenocarcinoma.

Chen L, Cao MF, Xiao JF, Ma QH, Zhang H, Cai RL, Miao JY, Wang WY, Zhang H, Luo M, Ping YF, Yao XH, Cui YH, Zhang X, Bian XW. Chen L, et al. Among authors: wang wy. Hum Pathol. 2020 Mar;97:68-79. doi: 10.1016/j.humpath.2019.12.007. Epub 2020 Jan 9. Hum Pathol. 2020. PMID: 31926212

4

Tumor mutational burden is associated with poor outcomes in diffuse glioma.

Wang L, Ge J, Lan Y, Shi Y, Luo Y, Tan Y, Liang M, Deng S, Zhang X, Wang W, Tan Y, Xu Y, Luo T. Wang L, et al. BMC Cancer. 2020 Mar 12;20(1):213. doi: 10.1186/s12885-020-6658-1. BMC Cancer. 2020. PMID: 32164609 Free PMC article.

5

Grincamycin B Functions as a Potent Inhibitor for Glioblastoma Stem Cell via Targeting RHOA and PI3K/AKT.

Yao Y, Sun S, Cao M, Mao M, He J, Gai Q, Qin Y, Yao X, Lu H, Chen F, Wang W, Luo M, Zhang H, Huang H, Ju J, Bian XW, Wang Y. Yao Y, et al. ACS Chem Neurosci. 2020 Aug 5;11(15):2256-2265. doi: 10.1021/acschemneuro.0c00206. Epub 2020 Jul 8. ACS Chem Neurosci. 2020. PMID: 32584547

6

Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling.

Zhang XN, Yang KD, Chen C, He ZC, Wang QH, Feng H, Lv SQ, Wang Y, Mao M, Liu Q, Tan YY, Wang WY, Li TR, Che LR, Qin ZY, Wu LX, Luo M, Luo CH, Liu YQ, Yin W, Wang C, Guo HT, Li QR, Wang B, Chen W, Wang S, Shi Y, Bian XW, Ping YF. Zhang XN, et al. Among authors: wang wy, wang y, wang qh, wang c, wang s, wang b. Cell Res. 2021 Oct;31(10):1072-1087. doi: 10.1038/s41422-021-00528-3. Epub 2021 Jul 8. Cell Res. 2021. PMID: 34239070 Free PMC article.

7

Overexpression of carnitine palmitoyltransferase 1A promotes mitochondrial fusion and differentiation of glioblastoma stem cells.

Luo M, Liu YQ, Zhang H, Luo CH, Liu Q, Wang WY, He ZC, Chen C, Zhang XN, Mao M, Yang KD, Wang C, Chen XQ, Fu WJ, Niu Q, Bian XW, Shi Y, Ping YF. Luo M, et al. Among authors: wang wy, wang c. Lab Invest. 2022 Jul;102(7):722-730. doi: 10.1038/s41374-021-00724-0. Epub 2021 Dec 28. Lab Invest. 2022. PMID: 34963686 Free article.

8

Identification of a unique tumor cell subset employing myeloid transcriptional circuits to create an immunomodulatory microenvironment in glioblastoma.

Yang K, Shi Y, Luo M, Mao M, Zhang X, Chen C, Liu Y, He Z, Liu Q, Wang W, Luo C, Yin W, Wang C, Niu Q, Zeng H, Bian XW, Ping YF. Yang K, et al. Oncoimmunology. 2022 Jan 26;11(1):2030020. doi: 10.1080/2162402X.2022.2030020. eCollection 2022. Oncoimmunology. 2022. PMID: 35096487 Free PMC article.

9

HOXA5 is amplified in glioblastoma stem cells and promotes tumor progression by transcriptionally activating PTPRZ1.

He ZC, Liu Q, Yang KD, Chen C, Zhang XN, Wang WY, Zeng H, Wang B, Liu YQ, Luo M, Li L, Niu Q, Lu HM, Luo T, Yao XH, Guo HT, Ji JL, Cao MF, Shi Y, Ping YF, Bian XW. He ZC, et al. Among authors: wang wy, wang b. Cancer Lett. 2022 May 1;533:215605. doi: 10.1016/j.canlet.2022.215605. Epub 2022 Feb 24. Cancer Lett. 2022. PMID: 35219772

10

Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas.

Wang YX, Wu H, Ren Y, Lv S, Ji C, Xiang D, Zhang M, Lu H, Fu W, Liu Q, Yan Z, Ma Q, Miao J, Cai R, Lan X, Wu B, Wang W, Liu Y, Wang DZ, Cao M, He Z, Shi Y, Ping Y, Yao X, Zhang X, Zhang P, Wang JM, Wang Y, Cui Y, Bian XW. Wang YX, et al. Signal Transduct Target Ther. 2022 Mar 11;7(1):72. doi: 10.1038/s41392-022-00890-7. Signal Transduct Target Ther. 2022. PMID: 35273141 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,126 results

Search Page